Tyme Technologies Operating Expenses 2011-2025 | TYME

Annual Operating Expenses Tyme Technologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
27.2 M	25.8 M	29.3 M	19.4 M	15.2 M	-	8.6 M	53.9 K	56.6 K	27.4 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
29.3 M	27.4 K	14 M

Quarterly Operating Expenses Tyme Technologies

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	6.61 M	-	5.89 M	18.5 M	6.65 M	-	5.87 M	5.87 M	7.32 M	7.77 M	6.54 M	6.54 M	6.25 M	6.18 M	8.08 M	8.08 M	7.01 M	5.31 M	5.56 M	5.3 M	3.19 M	3.19 M	2.99 M	2.99 M	3.12 M	6.01 M	2.44 M	2.44 M	2.32 M	1.75 M	-	888 K	147 K	128 K	-	13.4 K	24 K	7.27 K	-	13.1 K	10.8 K	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
18.5 M	7.27 K	4.47 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aptevo Therapeutics APVO	-31.8 M	$ 0.55	-10.23 %	$ 152 K	USA
Aclaris Therapeutics ACRS	92.7 M	$ 3.03	-0.17 %	$ 234 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.09	-2.68 %	$ 7.43 B	Australia
Autolus Therapeutics plc AUTL	145 M	$ 1.79	7.19 %	$ 457 M	Britain
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 1.18	3.07 %	$ 6.43 M	China
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Ascendis Pharma A/S ASND	338 M	$ 208.29	-0.33 %	$ 5 B	Danmark
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
BioVie BIVI	18.1 M	$ 1.2	-0.77 %	$ 1.77 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.19	-12.16 %	$ 413 M	Israel
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	512 M	$ 94.51	-0.01 %	$ 27.2 B	Germany
Catalyst Biosciences CBIO	176 M	$ 12.02	-2.67 %	$ 791 M	USA
Amphastar Pharmaceuticals AMPH	168 M	$ 27.09	-0.11 %	$ 1.31 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Anika Therapeutics ANIK	51.6 M	$ 9.53	-0.21 %	$ 140 M	USA
Certara CERT	232 M	$ 8.86	-0.39 %	$ 1.42 B	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Cellectis S.A. CLLS	109 M	$ 4.93	3.79 %	$ 116 M	France
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	1.18 B	$ 581.66	-0.37 %	$ 44.1 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.45	-	$ 15.4 M	USA
AstraZeneca PLC AZN	17.6 B	$ 92.77	-0.14 %	$ 96.9 B	Britain
ChromaDex Corporation CDXC	53.9 M	-	-0.88 %	$ 598 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	106 M	$ 9.21	1.32 %	$ 1.49 B	Britain
Celldex Therapeutics CLDX	58.1 M	$ 26.14	-1.0 %	$ 1.68 M	USA